The Current and Future Place of Vinorelbine in Cancer Therapy
- 1 January 1992
- journal article
- clinical trial
- Published by Springer Nature in Drugs
- Vol. 44 (Supplement), 36-45
- https://doi.org/10.2165/00003495-199200444-00005
Abstract
Vinorelbine is a new semisynthetic vinca alkaloid that differs chemically from vinblastine by a substitution of the catharanthine moiety. The antitumour activity of vinorelbine against murine tumours,...Keywords
This publication has 41 references indexed in Scilit:
- [Analytical limits in clinical pharmacokinetics: example of vinca-alkaloids].1991
- The synthesis of Navelbine prototype of a new series of vinblastine derivatives.1989
- Biochemical effects of Navelbine on tubulin and associated proteins.1989
- Phase-II study of Navelbine in advanced breast cancer.1989
- Vinca alkaloids in the treatment of non-small cell lung cancerCancer Treatment Reviews, 1987
- RADIOIMMUNOASSAY AND PRELIMINARY PHARMACOKINETIC STUDIES IN RATS OF 5'-NORANHYDROVINBLASTINE (NAVELBINE)1984
- Chemotherapy of breast cancer: Current views and resultsInternational Journal of Radiation Oncology*Biology*Physics, 1983
- PHASE-II STUDY OF VINDESINE IN PATIENTS WITH ADVANCED BREAST-CANCER1982
- Prolonged disease-free survival in advanced breast cancer treated with "super-CMF" adriamycin: an alternating regimen employing high-dose methotrexate with citrovorum factor rescue.1981
- Tubulin aggregation and disaggregation: mediation by two distinct vinblastine-binding sites.Proceedings of the National Academy of Sciences, 1976